🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Frank G. Keller

Emory University

ORCID: 0000-0001-6165-5666

Also affiliated with Center for Cancer and Blood Disorders, Aflac (United States), Waldburg-Zeil Kliniken, Children's Healthcare of Atlanta

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile
0.208Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Accelerating pediatric Hodgkin lymphoma research: the Hodgkin Lymphoma Data Collaboration (NODAL)

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae013
Top 65%
0.208DataRank
Top 65%3 citations

Suzi Birz, Sharon M. Castellino, Tara O. Henderson, John T. Lucas, Qinglin Pei +36 more

Papers

Driven by 12 papers — median percentile 35. Top paper: “Performance of the FACT-GOG-Ntx to assess chemotherapy-induced peripheral neuropathy (CIPN) in pediatric high risk Hodgkin lymphoma: report from the Children’s Oncology Group AHOD 1331 study”.

Performance of the FACT-GOG-Ntx to assess chemotherapy-induced peripheral neuropathy (CIPN) in pediatric high risk Hodgkin lymphoma: report from the Children’s Oncology Group AHOD 1331 study

Journal of Patient-Reported Outcomes(2023)10.1186/s41687-023-00653-0
N/A
0.569DataRank · unranked
14 citations

Angie Mae Rodday, Qinglin Pei, Frank G. Keller, Yue Wu, Tara O. Henderson +4 more

Targeted radiotherapy for early-stage, low-risk pediatric Hodgkin lymphoma slow early responders: a COG AHOD0431 analysis

Blood(2022)10.1182/blood.2022016098
N/A
0.531DataRank · unranked
14 citations

Frank G. Keller, Kathleen M. McCarten, Sandy Kessel, Steve Cho, Qinglin Pei +8 more

Identification of novel hypermethylated or hypomethylated CpG sites and genes associated with anthracycline-induced cardiomyopathy

Scientific Reports(2023)10.1038/s41598-023-39357-2
N/A
0.471DataRank · unranked
11 citations

Liting Zhou, Disheet Shah, Romina B. Cejas, David K. Crossman, Mariam Jouni +18 more

Importance of Central Imaging Review in a Pediatric Hodgkin Lymphoma Trial Using Positron Emission Tomography Response Adapted Radiation Therapy

International Journal of Radiation Oncology*Biology*Physics(2023)10.1016/j.ijrobp.2023.02.020
N/A
0.330DataRank · unranked
7 citations

Kathleen M. McCarten, Qinglin Pei, Sandy Kessel, Adina Alazraki, Joyce Mhlanga +12 more

Comparison of Contemporary Radiation Therapy Approaches in Combined Modality Treatment on Pediatric High-Risk Classic Hodgkin Lymphoma Study: AHOD 1331

International Journal of Radiation Oncology*Biology*Physics(2025)10.1016/j.ijrobp.2025.06.3876
N/A
0.292DataRank · unranked
6 citations

Raymond B. Mailhot Vega, Lindsay A. Renfro, Qinglin Pei, Anne-Marie Charpentier, Rahul R. Parikh +15 more

Accelerating pediatric Hodgkin lymphoma research: the Hodgkin Lymphoma Data Collaboration (NODAL)

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae013
Top 65%
0.208DataRank
Top 65%3 citations

Suzi Birz, Sharon M. Castellino, Tara O. Henderson, John T. Lucas, Qinglin Pei +36 more

PATTERNS OF PRESENTATION AND OUTCOMES IN STAGE IV HODGKIN LYMPHOMA: A REPORT FROM THE CHILDREN’S ONCOLOGY GROUP (COG) AHOD1331 TRIAL

Hematological Oncology(2023)10.1002/hon.3163_34
N/A
0.104DataRank · unranked
1 citations

Kathleen M. McCarten, Qinglin Pei, Sarah A. Milgrom, Joseph L. Belsky, S. Cho +6 more

Enhancing Radiotherapy Quality Assurance in Lymphoma: A Rigorous Real-Time Central Review Process

International Journal of Radiation Oncology*Biology*Physics(2025)10.1016/j.ijrobp.2025.06.3203
N/A
0DataRank · unranked
0 citations

S.A. Milgrom, Raymond B. Mailhot Vega, David Hodgson, Henry Chapman, Sandra Kessel +15 more

Combination brentuximab vedotin and bendamustine for pediatric patients with relapsed/refractory Hodgkin lymphoma

Blood Advances(2021)10.1182/bloodadvances.2021005268
N/A
0DataRank · unranked
22 citations

Nitya Gulati, Audrey Mauguen, Michael J. Absalon, Sharon M. Castellino, Anna R. Franklin +3 more

Brentuximab vedotin and association with event-free survival (EFS) in children with newly diagnosed high-risk Hodgkin lymphoma (HL): A report from the Children's Oncology Group phase 3 study AHOD1331 (NCT 02166463).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.7504
N/A
0DataRank · unranked
5 citations

Qinglin Pei, Susan K. Parsons, David Hodgson, Kathleen M. McCarten, Angela Punnett +9 more

Alternative mRNA splicing in anthracycline-induced cardiomyopathy – a COG-ALTE03N1 report

Cardio-Oncology(2025)10.1186/s40959-025-00345-2
N/A
0DataRank · unranked
2 citations

David K. Crossman, Changde Cheng, Patrick J. Trainor, Noha Sharafeldin, Xuexia Wang +12 more

Impact of respiratory viral panel testing on length of stay in pediatric cancer patients admitted with fever and neutropenia

Pediatric Blood & Cancer(2020)10.1002/pbc.28570
N/A
0DataRank · unranked
17 citations

Martha Wetzel, Nicholas P. DeGroote, Frank G. Keller, Michael Briones, James Felker +3 more